Rewriting the Muscle Code: The Breakthrough Era in the Duchenne Muscular Dystrophy Treatment Market
  Duchenne Muscular Dystrophy (DMD) has long been one of the most heartbreaking genetic diagnoses. A rare, muscle-wasting disease that primarily affects boys, DMD is caused by a lack of dystrophin, a protein that keeps muscle cells intact. Historically, treatment was limited to managing symptoms with corticosteroids, but we are now in the midst of a therapeutic revolution. The emergence of...
0 Комментарии 0 Поделились 35 Просмотры 0 предпросмотр